Posts by: Inês Martins, PhD

Inês Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

July 25, 2016July 25, 2016

PUR0200, an Inhaled Bronchodilator for COPD, Shows Promise in Pilot Study

COPD, News

PUR0200, a new dry powder formulation being developed for the treatment of chronic obstructive pulmonary disease (COPD), has shown positive pharmacokinetic results in a Phase 1 pilot study. The results were ... Read more

June 24, 2016June 24, 2016

Pulmonary Arterial Hypertension Severity Could Be Assessed in Future with a Blood Test

News, Pulmonary Hypertension

Researchers at Johns Hopkins University School of Medicine, in Maryland, revealed that hematoma derived growth factor (HDGF) might be a good biomarker to predict disease severity in pulmonary arterial hypertension (PAH) patients. The findings were recently published ... Read more

June 13, 2016June 13, 2016

FDA Approves First Blood Test to Detect Specific Mutations in Non-Small Cell Lung Cancer

Lung Cancer, News

The U.S Food and Drug Administration (FDA) has approved the first blood-based genetic test designed to detect mutations in the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC) ... Read more

May 31, 2016May 31, 2016

Lung Metastasis in Mice Prevented by Targeting a Key Cancer Protein, Researchers Find

Lung Cancer, News

Researchers at Brown University demonstrated that controlling a key protein involved in cancer, through the activation of a specific immune response, can prevent cancer metastasis in mice’s lungs. The findings are described in ... Read more

May 25, 2016May 25, 2016

COPD Patients in US Face Significant Challenges in Accessing Treatment, Researchers Say

COPD, News

Leading U.S. experts in chronic obstructive pulmonary disease (COPD) have found that patients with the condition face substantial barriers in assessing care, with hospitals failing to provide recommended standard of care, ... Read more

May 23, 2016May 23, 2016

Acute COPD Improved by Inhibitor, Approved Bronchodilators

COPD, News

Verona Pharma has announced positive results from the Phase 2a trial evaluating a phosphodiesterase (PDE) 3/4 inhibitor, RPL554, in patients with chronic obstructive pulmonary disorder (COPD). COPD is a progressive ... Read more

May 6, 2016May 6, 2016

Concert Pharmaceuticals Announces Promising Phase 1 Trial Data on Modified Version of CF Treatment Ivacaftor

Cystic Fibrosis, News

Promising clinical data from a Phase 1 multiple ascending trial of a deuterium-modified version of the commercially available Kalydeco® (ivacaftor), a drug used to treat cystic fibrosis (CF) in patients ... Read more

April 27, 2016April 28, 2016

New Insights into IPF Lung Disease Revealed with 3D Imaging Technique

Idiopathic Pulmonary Fibrosis, News

An advanced 3D X-ray imaging technique was applied for the first time to idiopathic pulmonary fibrosis (IPF) patients, providing new insight into how this aggressive disease develops in the body. The ... Read more